Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
NextCure, Inc. - Common Stock, $0.001 par value (NXTC) Institutional Ownership
CUSIP: 65343E207
13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025
Institutions Reporting
24
Shares (Excl. Options)
1,897,561
Price
$14.19
- Type / Class
- Equity / Common Stock, $0.001 par value
- Symbol
- NXTC on Nasdaq
- Shares outstanding
- 3,135,972
- Price per share
- $13.21
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,897,561
- Total reported value
- $26,925,657
- % of total 13F portfolios
- 0%
- Share change
- +824,352
- Value change
- +$12,224,139
- Number of holders
- 24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NXTC - NextCure, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 65343E207.
- 24 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 16 to 24 between Q3 2025 and Q4 2025.
- Reported value moved from $4,898,495 to $26,925,657.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 65343E207?
CUSIP 65343E207 identifies NXTC - NextCure, Inc. - Common Stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 65343E207:
Significant Owners of NextCure, Inc. - Common Stock, $0.001 par value (NXTC) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 10% | $4,715,825 | 363,035 | Ikarian Capital, LLC | 31 Dec 2025 | |||
| Affinity Asset Advisors, LLC | 10% | +40% | $4,375,018 | +$1,966,899 | 348,607 | +82% | Affinity Asset Advisors, LLC | 22 Jan 2026 |
| Simcere Zaiming, Inc. | 13% | $1,696,566 | 338,636 | Simcere Zaiming, Inc. | 20 Jun 2025 | |||
| Squadron Capital Management LLC | 9.9% | +49% | $3,521,940 | +$1,263,485 | 271,127 | +56% | Squadron Master Fund LP | 31 Dec 2025 |
| Sofinnova Venture Partners IX, L.P. | 7.1% | $2,947,939 | 222,654 | Sofinnova Venture Partners IX, L.P. ("SVP IX") | 19 Dec 2025 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 5% | $2,286,980 | 176,057 | SilverArc Capital Management, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 24 institutional investors reported holding 1,897,561 shares of NextCure, Inc. - Common Stock, $0.001 par value (NXTC). This represents 61% of the company’s total 3,135,972 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of NextCure, Inc. - Common Stock, $0.001 par value (NXTC) together control 61% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 7.9% | 247,294 | +29% | 0.25% | $3,509,102 |
| Ikarian Capital, LLC | 7.6% | 238,303 | 0.44% | $3,381,520 | |
| Squadron Capital Management LLC | 7.6% | 236,966 | 0% | 1.5% | $3,362,548 |
| Sofinnova Investments, Inc. | 7.1% | 222,654 | 0% | 0.14% | $3,159,460 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.6% | 176,057 | 0.36% | $2,498,249 | |
| Exome Asset Management LLC | 5.3% | 165,000 | 1.2% | $2,341,350 | |
| Pfizer Inc | 5% | 157,646 | 0% | 0.95% | $2,236,997 |
| AWM Investment Company, Inc. | 3.7% | 117,371 | 0.16% | $1,665,494 | |
| VANGUARD GROUP INC | 2.9% | 91,910 | +35% | 0% | $1,304,203 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.2% | 69,617 | 0.03% | $987,865 | |
| RENAISSANCE TECHNOLOGIES LLC | 1.1% | 33,634 | +19% | 0% | $477,266 |
| BlackRock, Inc. | 0.89% | 27,793 | -11% | 0% | $394,383 |
| ACADIAN ASSET MANAGEMENT LLC | 0.85% | 26,765 | -27% | 0% | $379,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.74% | 23,157 | +19% | 0% | $328,660 |
| CARDIFF PARK ADVISORS, LLC | 0.7% | 21,833 | 0.03% | $309,810 | |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 13,033 | 0% | $184,938 | |
| MARSHALL WACE, LLP | 0.36% | 11,292 | 0% | $160,233 | |
| Sio Capital Management, LLC | 0.35% | 10,940 | 0% | 0.03% | $155,239 |
| BARCLAYS PLC | 0.18% | 5,626 | 0% | 0% | $79,833 |
| UBS Group AG | 0.01% | 338 | -44% | 0% | $4,796 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 173 | +652% | 0% | $2,454 |
| MORGAN STANLEY | 0% | 66 | 0% | $937 | |
| JPMORGAN CHASE & CO | 0% | 61 | 0% | 0% | $866 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 32 | 0% | 0% | $454 |
| Cable Car Capital, LP | 0% | 0 | -100% | $0 |